Introduction {#s1}
============

Within a species, organ size is remarkably reproducible. While extrinsic factors like hormones are required for growth, classic transplantation experiments indicate that intrinsic factors within organs determine size ([@bib7]). For example, embryonic limb buds transplanted from a large species of salamander onto a small species grow to the size characteristic of the donor ([@bib52]). Similar findings have been made in quail and chick limbs ([@bib26]; [@bib57]), rat hearts and kidneys ([@bib10]; [@bib43]), and mouse thymuses ([@bib32]). Consistently, developing *Drosophila* wings transplanted into adult abdomens grow to the proper size, indicating that the information determining size is located within the developing organ ([@bib13]). Indeed, the *Drosophila* wing is a classic model system for studying organ size, as its size is highly replicable ([@bib15]; [@bib13]), and all adult precursor cells are located within the pouch region of the developing larval imaginal disc ([@bib16]) ([Figure 1A](#fig1){ref-type="fig"}, grey). Despite extensive work, the molecular mechanisms underlying intrinsic organ size control remain unclear ([@bib54]). While morphogens direct both patterning and growth of developing organs ([@bib50]), a link between patterning molecules and growth control pathways has not been established ([@bib41]).10.7554/eLife.11491.003Figure 1.Localized JNK activity exists in the developing wing.(**A**) Schematic of wing precursor cells (grey) in the developing disc (A, anterior; P, posterior). (**B-F**) Antibody staining against active, phosphorylated JNK (pJNK, green; DAPI, blue) labels a stripe in wildtype (**B-C**) but not JNKK mutant (**D-E**, *hep^r75/Y^*) third instar discs. Boxed region in (**B**) and (**D**) is magnified in (**C**) and (**E**), respectively. Weak pJNK signal is also detected along the dorsal/ventral boundary. pJNK stripe staining is lost in JNKK mutant clones (**F**, *hep^r75^*, clone is negatively marked in **F'**). (**G-I**) pJNK localizes to the same cells in which *ptc* is expressed (**G**, *ptc\>RFP,* red) along the A/P boundary, and is lost following JNK phosphatase expression (**H**, *ptc\>puc, RFP*, red) or RNAi-mediated knockdown of *bsk* within the *ptc* domain (**I**, *ptc\>bsk^RNAi^, RFP,* red). Bar: 50 um (**B-F**, **H-I**) and 25 um (**G**). See also [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.11491.003](10.7554/eLife.11491.003)10.7554/eLife.11491.004Figure 1---figure supplement 1.pJNK recognizes endogenous JNK activity in developing wing discs.Related to [Figure 1](#fig1){ref-type="fig"}. (**A-C**) Wildtype *Canton-S* wing discs stained for DAPI (blue) and pJNK (green) during (**A**) early third instar (L3), (**B**) mid-third instar, and (**C**) late third instar. (**D**) Wing disc stained for DAPI (blue), pJNK (green), and *puc-lacZ* (red). Boxes indicate areas enlarged in **E** and **F**. (**E**) Notum cells are positive for pJNK and *puc-lacZ*. (**F**) Blade cells show a stripe of pJNK staining but no detectable *puc-lacZ*. (**G-H**) A second, independently generated antibody against pJNK from Promega shows a similar pattern in third instar discs. (**G**) Whole wing disc and (**H**) wing blade. (**I**) Inhibition of JNK signaling in the dorsal compartment reduces pJNK staining (green) (*ap\>puc*). (**J**) *ptc-Gal4* expresses in a stripe in early L3 stage. (**K**) Inhibition of JNK in all wing blade cells (*rn\>bsk^RNAi\#1^, RFP*) or (**L**) in *ptc* cells (*ptc\>bsk^RNAi\#2^, RFP*) eliminates pJNK (green) signal. (**M**) Western blot analysis of larval extracts from *Canton-S* (Lane 1) and *hep^r75/Y^* (Lane 2) animals. pJNK is predicted to be \~43kD. Loading control (bottom) is alpha-tubulin. Bar: 50 um.**DOI:** [http://dx.doi.org/10.7554/eLife.11491.004](10.7554/eLife.11491.004)

The Jun N-terminal Kinase (JNK) pathway promotes proliferation during regeneration and tumor growth ([@bib6]; [@bib23]; [@bib40]; [@bib44]; [@bib58]). In fact, JNK-induced proliferation is often non-autonomous ([@bib12]; [@bib35]; [@bib40]; [@bib47]; [@bib58]). Basket (Bsk) is the singular *Drosophila* JNK and is activated by phosphorylation by the JNKK Hemipterous (Hep) ([@bib18]; [@bib45]). Canonical JNK signaling acts through the transcription co-factor Jun, which regulates migration and apoptosis ([@bib45]). Although the role of JNK in activating Yorkie signaling and growth during regeneration and tumorigenesis is clear ([@bib12]; [@bib47]; [@bib48]), it is not known to regulate proliferation and growth during developmental size control.

Here we show that localized JNK activity in the developing wing is established by Hedgehog (Hh) signaling and controls wing size through a non-canonical, Jun-independent signaling mechanism that inhibits the Hippo pathway.

Results and discussion {#s2}
======================

JNK is active in the developing *Drosophila* wing pouch {#s2-1}
-------------------------------------------------------

Two independently generated antibodies that recognize the phosphorylated, active form of JNK (pJNK) specifically label a stripe in the pouch of developing wildtype third instar wing discs ([Figure 1B--C](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1G--H](#fig1s1){ref-type="fig"}). Importantly, localized pJNK staining is not detected in hemizygous *JNKK* mutant discs ([Figure 1D--E](#fig1){ref-type="fig"}; *hep^r75^/Y*), in clones of *JNKK* mutant cells within the stripe ([Figure 1F](#fig1){ref-type="fig"}; *hep^r75^, FRT10/Ubi-GFP, FRT10;; MKRS, hs-FLP/+*), following over-expression of the JNK phosphatase *puckered (puc*) ([Figure 1---figure supplement 1I](#fig1s1){ref-type="fig"}; *ap-Gal4, UAS-puc*), or following RNAi-mediated knockdown of *bsk* using two independent, functionally validated RNAi lines ([Figure 1---figure supplement 1K--L](#fig1s1){ref-type="fig"}; *rn-Gal4, UAS-bsk^RNAi\#1^*or *ptc-Gal4, UAS-bsk^RNAi\#2^*; see Experimental Genotypes for full genotypes and conditions) ([@bib18]; [@bib29]; [@bib30]; [@bib36]; [@bib55]; [@bib59]).

The stripe of localized pJNK staining appeared to be adjacent to the anterior-posterior (A/P) compartment boundary, a location known to play a key role in organizing wing growth, and a site of active Hedgehog (Hh) signaling ([@bib4]; [@bib49]; [@bib60]). Indeed, pJNK co-localizes with the Hh target gene *patched (ptc*) ([Figure 1G](#fig1){ref-type="fig"}; *ptc-Gal4, UAS-RFP*). Expression of the JNK phosphatase *puc* in these cells specifically abrogated pJNK staining ([Figure 1H](#fig1){ref-type="fig"}; *ptc-Gal4, UAS-puc*), as did RNAi-mediated knockdown of *bsk* ([Figure 1I](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1L](#fig1s1){ref-type="fig"}; *ptc-Gal4, UAS-bsk^RNA\#i1or2^*). Together, these data indicate that the detected pJNK signal reflects endogenous JNK signaling activity in the *ptc* domain, a region of great importance to growth control. Indeed, while at earlier developmental stages pJNK staining is detected in all wing pouch cells ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}), the presence of a localized stripe of pJNK correlates with the time when the majority of wing disc growth occurs (1000 cells/disc at mid-L3 stage to 50,000 cells/disc at 20 hr after pupation, ([@bib14]), so we hypothesize that localized pJNK plays a role in regulating growth.

Localized JNK activity regulates global wing size {#s2-2}
-------------------------------------------------

Inhibition of JNK signaling in the posterior compartment previously led to the conclusion that JNK does not play a role in wing development ([@bib31]). The discovery of an anterior stripe of JNK activity spurred us to re-examine the issue. Since *bsk* null mutant animals are embryonic lethal, we thus conditionally inhibited JNK signaling in three independent ways in the developing wing disc. JNK inhibition was achieved by RNAi-mediated knockdown of *bsk (bsk^RNAi\#1or2^*), by expression of JNK phosphatase (*puc*), or by expression of a dominant negative *bsk (bsk^DN^*). These lines have been independently validated as JNK inhibitors ([@bib29]; [@bib30]; [@bib36]; [@bib55]). Inhibition of JNK in all wing blade cells (*rotund-Gal4, rn-Gal4*) or specifically in *ptc-*expressing cells (*ptc-Gal4*) resulted in smaller adult wings in all cases, up to 40% reduced in the strongest cases ([Figures 2A--F, 2J--K](#fig2){ref-type="fig"}, and [Figure 2---figure supplement 1D](#fig2s1){ref-type="fig"}). Importantly, expression of a control transgene (*UAS-GFP*) did not affect wing size ([Figure 2---figure supplement 1B--C](#fig2s1){ref-type="fig"}; *ptc-Gal4, UAS-GFP*). This contribution of JNK signaling to size control is likely an underestimate, as the embryonic lethality of *bsk* mutations necessitates conditional, hypomorphic analysis. Nevertheless, hypomorphic *hep^r75^/Y* animals, while pupal lethal, also have smaller wing discs ([Figure 2---figure supplement 1G](#fig2s1){ref-type="fig"}), as do animals with reduced JNK signaling due to *bsk^DN^* expression ([Figure 2---figure supplement 1H--I](#fig2s1){ref-type="fig"}; *ap-Gal4, UAS-bsk^DN^*). Importantly, total body size is not affected by inhibiting JNK in the wing. Even for the smallest wings generated (*rn-Gal4, UAS-bsk^DN^*), total animal body size is not altered ([Figure 2---figure supplement 1A,E](#fig2s1){ref-type="fig"}).10.7554/eLife.11491.005Figure 2.Modulation of localized JNK signaling changes wing size.Inhibition of JNK in all wing blade cells (**B-E, J**) or within the *ptc* domain (**F, K**) decreases adult wing size compared to controls (**A, C-E, J**, *rn\>)* or (**F, K**, *ptc\>*). Note that autonomous reduction between longitudinal veins 3 and 4 accounts for a small portion of the global reduction. Apoptosis inhibition does not rescue the small wing phenotype (red, **G**, *rn\>p35, bsk^DN^*). (**H-I, L**) Increased JNK signaling within the *ptc* domain following *eiger* expression causes an increase in disc size (**I**, *ptc\>egr, RFP*, red; DAPI, blue) compared to controls (**H**, *ptc\>RFP*, red). (**L**) This is increase is dependent on *bsk (ptc\>egr, bsk^DN^*) but not affected by *diap1* or *p35* expression (*ptc\>egr, diap1* or *ptc\>egr, p35*). Due to high pupal lethality, disc size was analyzed when animals reached the wandering third instar stage. (**M-O**) JNK inhibition does not affect cell size (**N-O**, *rn\>bsk^DN^*). (**P-Q**) Increased JNK signaling within the *ptc* domain causes an increase in proliferation (**Q**, *ptc\>egr, RFP*, red; EdU, green) compared to controls (**P**, *ptc\>RFP*, red; EdU, green). EdU of boxed region in (**P**) and (**Q**) is shown in (**R**) and (**S**), respectively. (**T**) Quantification of mean EdU signal in wing pouch regions between *ptc\>RFP* and *ptc\>egr* animals. Whiskers are SD. For box plots of area quantifications, whiskers represent maximum and minimum values (**J-L**, **O**). \*-\*\*\*\*=p\<0.05--0.0001. n.s.= not significant. Bar: 50 um. See also [Figure 2---figure supplements 1](#fig2s1){ref-type="fig"}--[4](#fig2s4){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.11491.005](10.7554/eLife.11491.005)10.7554/eLife.11491.006Figure 2---figure supplement 1.JNK inhibition does not affect body size or cell death, but rather cell proliferation.Related to [Figure 2.](#fig2){ref-type="fig"} (**A**) Control *rotund-Gal4 (rn\>*) alone female fly (left). Inhibiting JNK in the entire wing (*rn\>bsk^DN^*) leads to a female fly with smaller, well-patterned wings (right). Black bars highlight difference in wing size. (**B-C**) Expression of a control transgene (*UAS-GFP*) does not affect wing size (*ptc\>GFP*). (**D**) Quantification of relative wing size for knockdown of *bsk* with a second RNAi line (*bsk^RNAi\#2^*). (**E**) Adult body length is not affected by inhibiting JNK by *rn-Gal4*. (**F**) Inhibition of JNK with *rn-GAL4* delays development. (**G**) *hep^r75^/Y* animals have smaller wing discs than controls (*Canton-S* or *hep^r75^/+*), even when adjusted for delayed developmental time (7d AEL). (**H-I**) JNK inhibition (red, dorsal half) causes a reduction in wing pouch size compared to its matched control (blue, ventral half) (*ap\>bsk^DN^*, red). (J) JNK inhibition (dorsal half) reduces cell proliferation by phosphorylated histone 3 (PH3) staining (green) compared to its matched control (ventral half) (*ap\>bsk^DN^*). (**K**) Control discs (*ap\>RFP*, blue) do not show a difference in PH3 staining between dorsal and ventral halves (ratio = 1.04), while JNK inhibited ones do (Ratio = 0.86, red). (**L**) Control wing pouch (*rn\>RFP*, red) stained for cleaved Caspase 3 (CCP3, green). (**M**) Inhibition of JNK in all pouch cells (*rn\>bsk^DN^, RFP*, red) does not induce apoptosis as assayed by CCP3 staining (green). (**N**) Positive control expression of wildtype JNK (*bsk^AY^*) causes apoptosis and CCP3 staining (green). Two-sided student's t-test: \*-\*\*\*p\<0.05--0.001. Bar: 50 um.**DOI:** [http://dx.doi.org/10.7554/eLife.11491.006](10.7554/eLife.11491.006)10.7554/eLife.11491.007Figure 2---figure supplement 2.Activating JNK signaling increases wing disc size independent of cell death or developmental timing.Related to [Figure 2](#fig2){ref-type="fig"}. (**A-C**) Age-matched wing discs expressing *RFP* by *ptc-GAL4* (control, A) or *RFP* and *egr* by *ptc-GAL4* (**B**). (**C**) Wing disc area quantification for A-B. (**D-F**) Induction of apoptosis in the *ptc* domain reduces wing disc size. (**D**) Control *ptc\>RFP* wing. (**E**) Expression of *UAS-hid (ptc\>hid*) decreases wing size. (**F**) Quantification of **D-E**. (**G**) Size increase due to *egr* expression depends on *bsk* activity (*ptc\>egr, bsk^DN^*), but is not affected by expression of *diap1* (**G**, *ptc\>egr, diap1*) or *p35* (**I**, *ptc\>egr, p35*). Quantification of **G-I** is presented in [Figure 2L](#fig2){ref-type="fig"}. Two-sided student's t-test: \*-\*\*p\<0.05--0.01. Bar: 100 um.**DOI:** [http://dx.doi.org/10.7554/eLife.11491.007](10.7554/eLife.11491.007)10.7554/eLife.11491.008Figure 2---figure supplement 3.JNK inhibition does not affect Dpp or EGFR signaling.Related to [Figure 2](#fig2){ref-type="fig"}. (**A-C**) Wing discs stained for the EGFR reporter pERK (green). (**A**) Control wing disc (*ap\>RFP,* red). (**B**) Inhibition of EGFR signaling in the dorsal half of the disc (*ap\>EGFR^RNAi^, RFP,* red) decreases dorsal pERK (green) staining, while (**C**) inhibition ofJNK signaling (*ap\>bsk^DN^, RFP,* red) does not. (D-F) Wing discs stained for the Dpp reporter pSMAD (green). (**D**) Control (*ap\>RFP,* red). (**E**) Inhibition of Dpp signaling in the dorsal half of the disc (*ap\>dpp^RNAi^, RFP,* red) abolishes dorsal pSMAD (green) staining, while (**F**) inhibition of JNK signaling (*ap\>bsk^DN^, RFP,* red) does not. (**G**) Quantification of pSMAD fluorescence, as a ratio of dorsal to ventral staining. *ap\>dpp^RNAi^* causes a dramatic decrease in the ratio, while JNK inhibition (*ap\>bsk^DN^*) does not produce a statistically significant change (p=0.17). (**H**) pSMAD gradient fluorescence plot by distance along the A-P axis. Ventral (blue) is control, while dorsal (red) is knockdown of *dpp*. (**I**) pSMAD gradient fluorescence plot by distance along the A-P axis. Inhibiting JNK signaling (dorsal, red) does not affect pSMAD gradient formation (compare blue to red). (**J**) Control *rn-Gal4* alone control. (**K**) RNAi-mediated knockdown of *dpp* causes a reduction in wing veins and a more pronounced effect on AP than PD length. (**L**) Inhibition of JNK does not cause wing vein loss, but does cause a global reduction in size. AFU.: arbitrary fluorescence units. Bar: 50 um.**DOI:** [http://dx.doi.org/10.7554/eLife.11491.008](10.7554/eLife.11491.008)10.7554/eLife.11491.009Figure 2---figure supplement 4.Inhibiting EGFR or Dpp signaling does not affect pJNK establishment.Related to [Figure 2](#fig2){ref-type="fig"}. Inhibition of EGFR (**A**) or Dpp (**B**) by RNAi does not have an effect on pJNK (green). Bar: 50 um.**DOI:** [http://dx.doi.org/10.7554/eLife.11491.009](10.7554/eLife.11491.009)

To test whether elevation of this signal can increase organ size, we expressed *eiger (egr*), a potent JNK activator ([@bib22]), within the *ptc* domain (*ptc-Gal4, UAS-egr*). Despite induction of cell death as previously reported ([@bib22]) and late larval lethality, we observed a dramatic increase in wing disc size without apparent duplications or changes in the shape of the disc ([Figures 2H--I and 2L](#fig2){ref-type="fig"}; *ptc-Gal4, UAS-egr*). While changes in organ size could be due to changing developmental time, wing discs with elevated JNK signaling were already larger than controls assayed at the same time point ([Figure 2---figure supplement 2A--C](#fig2s2){ref-type="fig"}; *ptc-Gal4* and *ptc-Gal4, UAS-egr*). Similarly, inhibition of JNK did not shorten developmental time ([Figure 2---figure supplement 1F](#fig2s1){ref-type="fig"}; *rn-Gal4, UAS-bsk^DN^*). Thus, changes in organ size by modulating JNK activity do not directly result from altering developmental time. Finally, the observed increase in organ size is not due to induction of apoptosis, as expression of the pro-apoptotic gene *hid* does not increase organ size ([Figure 2---figure supplement 2D--F](#fig2s2){ref-type="fig"}). In contrast, it causes a decrease in wing size ([Figure 2---figure supplement 2D--F](#fig2s2){ref-type="fig"}). Furthermore, co-expression of *diap1* or *p35* did not significantly affect the growth effect of *egr* expression (p\>0.05; [Figure 2L](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2H--I](#fig2s2){ref-type="fig"}; *ptc-Gal4, UAS-egr, UAS-diap1* and *ptc-Gal4, UAS-egr, UAS-p35*), while the effect was dependent on Bsk activity (p\<0.05; [Figure 2L](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2G](#fig2s2){ref-type="fig"}; *ptc-Gal4, UAS-egr, UAS-bsk^DN^*).

In stark contrast to known developmental morphogens, we did not observe any obvious defects in wing venation pattern following JNK inhibition ([Figure 2A--B](#fig2){ref-type="fig"}), suggesting that localized pJNK may control growth in a pattern formation-independent manner. Indeed, even a slight reduction in Dpp signaling results in dramatic wing vein patterning defects ([Figure 2---figure supplement 3K](#fig2s3){ref-type="fig"}). Second, inhibiting Dpp signaling causes a reduction in wing size along the A-P axis, while JNK inhibition causes a global reduction ([Figure 2---figure supplement 3J--L](#fig2s3){ref-type="fig"}). Furthermore, ectopic Dpp expression increases growth in the form of duplicated structures ([@bib60]), while increased JNK signaling results in a global increase in size ([Figure 2H--I](#fig2){ref-type="fig"}). Molecularly, we confirm that reducing Dpp signaling abolishes pSMAD staining, while quantitative data shows that inhibiting JNK signaling does not ([Figure 2---figure supplement 3D--I](#fig2s3){ref-type="fig"}). Furthermore, we also find that Dpp is not upstream of pJNK, as reduction in Dpp signaling does not affect pJNK ([Figure 2---figure supplement 4B](#fig2s4){ref-type="fig"}). Together, the molecular data are consistent with the phenotypic results indicating that pJNK and Dpp are separate programs in regulating growth. Consistent with our findings, during the revision of this manuscript, it has been suggested that Dpp does not play a primary role in later larval wing growth control ([@bib1]). Finally, we found that inhibition of JNK does not affect EGFR signaling (pERK) and that inhibition of EGFR does not affect the establishment of pJNK ([Figure 2---figure supplement 3A--C](#fig2s3){ref-type="fig"} and [4A](#fig2s4){ref-type="fig"}).

A difference in size could be due to changes in cell size and/or number. We examined wings with reduced size due to JNK inhibition and did not detect changes in cell size or apoptosis ([Figure 2M--O](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1L--N](#fig2s1){ref-type="fig"}; *rn-Gal4, UAS-bsk^DN^*), suggesting that pJNK controls organ size by regulating cell number. Consistently, the cell death inhibitor *p35* was unable to rescue the decreased size following JNK inhibition ([Figure 2G](#fig2){ref-type="fig"}; *rn-Gal4, UAS-p35, UAS-bsk^DN^*). Indeed, inhibition of JNK signaling resulted in a decrease in proliferation ([Figure 2---figure supplement 1J--K](#fig2s1){ref-type="fig"}; *ap-Gal4, UAS-bsk^DN^*), while elevation of JNK signaling in the *ptc* domain resulted in an increase in cell proliferation in the enlarged wing disc ([Figure 2P--T](#fig2){ref-type="fig"}; *ptc-Gal4, UAS-egr*). Importantly, this increased proliferation is not restricted to the *ptc* domain, consistent with previous reports that JNK can promote proliferation non-autonomously ([@bib12]; [@bib35]; [@bib40]; [@bib47]; [@bib58]).

Non-canonical JNK signaling regulates size {#s2-3}
------------------------------------------

To determine the mechanism by which pJNK controls organ size, we first considered canonical JNK signaling through its target Jun ([@bib24]). Interestingly, RNAi-mediated knockdown of *jun* in *ptc* cells does not change wing size ([Figure 3A--B](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1C--F](#fig3s1){ref-type="fig"}; *ptc-Gal4, UAS-jun^RNAi\#1or2^*; Both RNAi lines can effectively inhibit *jun* activity, [Figure 3---figure supplement 1A--B](#fig3s1){ref-type="fig"}), which is consistent with previous analysis of *jun* mutant clones in the wing disc ([@bib28]). Furthermore, in agreement with this, a reporter of canonical JNK signaling downstream of *jun (puc-lacZ* \[[@bib39]\]) is not expressed in the pJNK stripe ([Figure 1---figure supplement 1F](#fig1s1){ref-type="fig"}). Finally, knockdown of *fos (kayak, kay*) alone or with *jun^RNAi^* did not affect wing size ([Figure 3---figure supplement 1G--H](#fig3s1){ref-type="fig"}; *rn-Gal4, UAS-kay^RNiA\#1or2^ and rn-Gal4, UAS-jun^RNAi\#1^, UAS-kay^RNiA\#1or2^*). Together, these data indicate that canonical JNK signaling through *jun* does not function in the pJNK stripe to regulate wing size.10.7554/eLife.11491.010Figure 3.Non-canonical JNK signaling regulates wing size.RNAi-mediated knockdown of *Jun* within the *ptc* stripe does not change adult wing size (**A-B**, red, *ptc\>jun^RNAi^* compared to blue, *ptc\>*). RNAi-mediated knockdown of *jub* does change global wing size (**C-D**, red, *ptc\>jub^RNAi^* compared to blue, *ptc\>*). Expression of *yki* in all wing cells (E-F, red, *rn\>yki, bsk^DN^* compared to blue, *rn\>*) or within the *ptc* stripe (**G-H**, red, *ptc\>bsk^DN^, yki* compared to blue, *ptc\>*) rescues wing size following JNK inhibition. RNAi-mediated knockdown or overexpression of *yki* in *ptc* cells decreases or enlarges wing size, respectively (**I-J**, red, *ptc\>yki^RNAi^*, blue, *ptc\>*, and K-L, red, *ptc\>yki*, blue, *ptc\>*). (**M-N**) Inhibition of JNK signaling does not enhance the phenotype of Yki inhibition alone (M, red, *ptc\>bsk^DN^, yki^RNAi^*; blue, *ptc\>yki^RNAi^*). (**O-P**) RNAi-mediated knockdown of *fj* modifies the Yki growth phenotype (**O**, red, *ptc\>yki, fj^RNAi^*; blue, *ptc\>yki*). For box plots, whiskers represent maximum and minimum values. \*\*\*\*=p\<0.0001. See also [Figure 3---figure supplements 1](#fig3s1){ref-type="fig"}--[2](#fig3s2){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.11491.010](10.7554/eLife.11491.010)10.7554/eLife.11491.011Figure 3---figure supplement 1.*Jun* RNAi line validation and loss of *kayak* phenotypes.Related to [Figure 3](#fig3){ref-type="fig"}. RNAi-mediated knockdown of *Jun* in *ap* domain cells decreases *puc* expression (*puc-lacZ*, green) (**B**) compared to controls (**A**). Dotted line indicates *puc+* cells that co-localize with *ap-Gal4*. Note decreased *puc-lacZ* staining in this domain following *Jun* inhibition. However, (**C-D**) inhibition of *Jun* in all wing cells by RNAi-mediated knockdown does not show a phenotype. (**E-F**) A second *Jun* RNAi line does not show a phenotype when expressed in *ptc*-expressing cells. (**G-H**) Inhibition of *kayak/fos* (red, *rn\>kay^RNAi^*) does not affect wing size, nor does inhibiting *jun* and *kay* together (green, *rn\>kay^RNAi^, jun^RNAi^*). Individually, *kay^RNAi^* lines induced a thorax closure defect when driven by *ap-Gal4*. For box plots, whiskers represent maximum and minimum values. Bar: 5**DOI:** [http://dx.doi.org/10.7554/eLife.11491.011](10.7554/eLife.11491.011)10.7554/eLife.11491.012Figure 3---figure supplement 2.JNK interacts with Yki to cause global changes in wing size.Related to [Figure 3](#fig3){ref-type="fig"}. (**A**) Schematic for measuring the ratio of anterior to posterior wing area. (**B**) Local (*ptc*-driven) inhibition of JNK or increased Yki expression affects the anterior and posterior compartments equally. (**C-D**) The effect of inhibiting JNK signaling can be partially suppressed in a *lats* heterozygous mutant background (**C**, red, *rn\>bsk^DN^; lats^e26-1^/+*). (**G-H**) Inhibition of *fj* alone does not change wing size (**G**, red, *ptc\>fj^RNAi^*, blue, *ptc\>*), albeit it slightly changes wing shape, likely due to its effect on polarity. (**I-J**) Over-expression of *fj* causes a decrease in wing size (**I**, red, *ptc\>fj*). For box plots, whiskers are maximum and minimum values. Two-sided student's t-test: \*-\*\*\*\*p\<0.05--0.0001.**DOI:** [http://dx.doi.org/10.7554/eLife.11491.012](10.7554/eLife.11491.012)

In search of such a non-canonical mechanism of JNK-mediated size control, we considered the Hippo pathway. JNK signaling regulates the Hippo pathway to induce autonomous and non-autonomous proliferation during tumorigenesis and regeneration via activation of the transcriptional regulator Yorkie (Yki) ([@bib3]; [@bib12]; [@bib47]). Recently it has been shown that JNK activates Yki via direct phosphorylation of Jub ([@bib48]). To test whether this link between JNK and Jub could account for the role of localized pJNK in organ size control during development, we performed RNAi-mediated knockdown of *jub* in the *ptc* stripe, and observed adults with smaller wings ([Figure 3C--D](#fig3){ref-type="fig"}; *ptc-Gal4, UAS-jub^RNAi\#1or2^*). Indeed, the effect of JNK loss on wing size can be partially suppressed in a heterozygous *lats* mutant background ([Figure 3---figure supplement 2C--D](#fig3s2){ref-type="fig"}; *rn-Gal4, UAS-bsk^DN^, lats^e26-1^/+*) and increasing downstream *yki* expression in all wing cells ([Figure 3E--F](#fig3){ref-type="fig"}; *rn-Gal4, UAS-yki, UAS-bsk^DN^*) or just within the *ptc* domain ([Figure 3G--H](#fig3){ref-type="fig"}; *ptc-Gal4, UAS-yki, UAS-bsk^DN^*) can rescue wing size following JNK inhibition. These results suggest that pJNK controls Yki activity autonomously within the *ptc* stripe, leading to a global change in cell proliferation. This hypothesis predicts that the Yki activity level within the *ptc* stripe influences overall wing size. Consistently, inhibition of JNK in the *ptc* stripe translates to homogeneous changes in anterior and posterior wing growth ([Figure 3---figure supplement 2A--B](#fig3s2){ref-type="fig"}). Similarly, overexpression or inhibition of Yki signaling in the *ptc* stripe also results in a global change in wing size ([Figure 3I--L](#fig3){ref-type="fig"} and [Figure 3---figure supplement 2A--B](#fig3s2){ref-type="fig"}; *ptc-Gal4, UAS-yki; ptc-Gal4, UAS-yki^RNAi^*).

It is important to note that the *yki* expression line used is wild-type Yki, which is still affected by JNK signaling. For this reason, the epistasis experiment was also performed with activated Yki, which is independent of JNK signaling (*UAS-yki^S111A,S168A,S250A.V5^;* [@bib34]). Expression of this activated Yki in the *ptc* stripe caused very large tumors and lethality (data not shown). Importantly, inhibiting JNK in this context did not affect the formation of these tumors or the lethality (data not shown; *ptc-Gal4, UAS-yki^S111A,S168A,S250A.V5^, UAS-bsk^DN^*). Furthermore, inhibiting both JNK and Yki together does not enhance the phenotype of Yki inhibition alone ([Figure 3M--N](#fig3){ref-type="fig"} and [Figure 3---figure supplement 2E--F](#fig3s2){ref-type="fig"}; *ptc-Gal4, UAS-yki^RNAi^, UAS-bsk^DN^ and ptc-Gal4, UAS-yki^RNAi^, UAS-puc*), further supporting the idea that Yki is epistatic to JNK, instead of acting in parallel processes.

Mutants of the Yki downstream target *four-jointed (fj*) have small wings with normal patterning, and *fj* is known to propagate Hippo signaling and affect proliferation non-autonomously ([@bib2]; [@bib20]; [@bib46]; [@bib53]; [@bib56]). Although RNAi-mediated knockdown of *fj* in *ptc* cells does not cause an obvious change in wing size, it is sufficient to block the Yki-induced effect on increasing wing size ([Figure 3O--P](#fig3){ref-type="fig"} and [Figure 3---figure supplement 2G--H](#fig3s2){ref-type="fig"}*; ptc-Gal4, UAS-yki, UAS-fj^RNAi^*and *ptc-Gal4, UAS-fj^RNAi^*). However, overexpression of *fj* also reduces wing size, which makes it not possible to test for a simple epistatic relationship (*ptc-Gal4, UAS-fj*; [Figure 3---figure supplement 2I--J](#fig3s2){ref-type="fig"}). Overall, these data are consistent with the notion that localized pJNK regulates wing size not by Jun-dependent canonical JNK signaling, but rather by Jun-independent non-canonical JNK signaling involving the Hippo pathway.

Hh sets up pJNK by elevating *dTRAF1* expression {#s2-4}
------------------------------------------------

While morphogens direct both patterning and growth of developing organs ([@bib50]), a link between patterning molecules and growth control pathways has not been established ([@bib41]). pJNK staining is coincident with *ptc* expression ([Figure 1G](#fig1){ref-type="fig"}), suggesting it could be established by Hh signaling. During development, posterior Hh protein travels across the A/P boundary, leading to activation of the transcription factor Cubitus interruptus (Ci) in the stripe of anterior cells ([@bib11]; [@bib42]). To test whether localized activation of JNK is a consequence of Hh signaling through Ci, we performed RNAi-mediated knockdown of *ci* and found that the pJNK stripe is eliminated ([Figure 4A--B](#fig4){ref-type="fig"}; *ptc-Gal4, UAS-ci^RNAi\#1or2^*). Consistently, adult wing size is globally reduced ([Figures 4D and 4G](#fig4){ref-type="fig"}). In contrast, we do not observe a change in pJNK stripe staining following RNAi-mediated knockdown of *dpp* or *EGFR* ([Figure 2---figure supplement 4A--B](#fig2s4){ref-type="fig"}). Expression of non-processable Ci leads to increased Hh signaling ([@bib38]). Expression of this active Ci in *ptc* cells leads to an increase in pJNK signal and larger, well-patterned adult wings ([Figures 4C,E](#fig4){ref-type="fig"}, and 4G; *ptc-Gal4, UAS-Ci^ACT^*). The modest size increase shown for *ptc\>Ci^ACT^* is likely due to the fact that higher expression of this transgene (at 25°C) leads to such large wings that pupae cannot emerge from their cases. For measuring wing size, this experiment was performed at a lower temperature (20°C, see Experimental Genotypes) so that the animals were still viable. Furthermore, inhibition of JNK in wings expressing active Ci blocks Ci's effects, and resulting wings are similar in size to JNK inhibition alone ([Figure 4F--G](#fig4){ref-type="fig"}*; ptc-Gal4, UAS-Ci^ACT^, UAS-bsk^DN^*). Together, these data indicate that Hh signaling through Ci is responsible for establishing the pJNK stripe.10.7554/eLife.11491.013Figure 4.Hh signaling through Ci establishes localized pJNK.RNAi-mediated knockdown of *Ci* in *ptc* cells abrogates pJNK (green) staining (**A-B**, *ptc\>Ci^RNAi^, RFP* compared to *ptc\>RFP*) and results in smaller adult wings (**D**, red, *ptc\>Ci^RNAi^* compared to blue, *ptc\>*). Expression of activated *Ci* in the *ptc* domain leads to increased pJNK staining (green) (**C**, *ptc\>Ci^ACT^, RFP*) and a larger wing (**E**, red, *ptc\>Ci^ACT^* compared to blue, *ptc\>*). Inhibition of JNK signaling in these cells blocks the effect of activated Ci (red, F, *ptc\>Ci^ACT^, bsk^DN^).* For the box plot (**G**), whiskers represent maximum and minimum values. \*\*\*-\*\*\*\*=p\<0.001--0.0001. Bar: 50 um.**DOI:** [http://dx.doi.org/10.7554/eLife.11491.013](10.7554/eLife.11491.013)

To determine the mechanism by which Ci activates the JNK pathway, we compared transcriptional profiles of posterior (red, *hh+*) and *ptc* domain cells (green, *ptc+*) isolated by FACS from third instar wing discs ([Figure 5A](#fig5){ref-type="fig"}; Materials and methods). Of the total 12,676 unique genes represented on the microarray, 50.4% (6,397) are expressed in *ptc* domain cells, posterior cells, or both (log~2~ normalized expression ≥6.5; [Figure 5---figure supplement 1A--D](#fig5s1){ref-type="fig"}; [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}; Materials and methods). We thresholded on a false discovery rate \<0.01 and fold change ≥1.5 and found that 5.7% (363) of expressed genes were upregulated in *ptc* cells and 3.8% (242) were downregulated ([Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}; [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}; Materials and methods). Hh pathway genes known to be differentially expressed are identified ([Figure 5B](#fig5){ref-type="fig"}). We next asked whether any JNK pathway genes are differentially expressed and found that *dTRAF1* expression is more than five-fold increased in *ptc* cells ([Figure 5C](#fig5){ref-type="fig"}), while other JNK pathway members are not differentially expressed ([Figure 5C](#fig5){ref-type="fig"}; [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}; [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}).10.7554/eLife.11491.014Figure 5.Hedgehog signaling establishes pJNK by elevating *dTRAF1* expression.(**A**) *ptc* cells (green, *ptc+*) and posterior cells (red, *hh+*) from third instar wing discs were dissociated and sorted by FACS. RNA was isolated and hybridized to microarrays. Differentially expressed genes were identified. (**B**) Hedgehog pathway genes known to be differentially expressed are identified. Genes upregulated in *ptc* cells (*ptc+*) compared to posterior (*hh+*) cells are highlighted in green and downregulated in red. Genes with log~2~ normalized expression ≥6.5 are considered expressed. (**C**) JNK pathway gene *dTRAF1* is \>5-fold upregulated in *ptc* cells. (**D-I**) RNAi-mediated knockdown of *dTRAF1* eliminates pJNK (green) staining (**E**, *ptc\>dTRAF^RNAi\#1^, RFP*, red) and leads to smaller adult wings (**F-I**, *rn\>dTRAF^RNAi\#1^* or *ptc\>dTRAF^RNAi\#1^*). (**J**) Ci inhibition causes a \~30% decrease in *dTRAF1* expression in 3^rd^ instar wing discs, relative to endogenous control *Rp49*. Whiskers are SD. For box plots, whiskers are maximum and minimum values (**H-I**). \*-\*\*\*\*=p\<0.05--0.0001. Bar: 50 um. See also [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}--[2](#fig5s2){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.11491.014](10.7554/eLife.11491.014)10.7554/eLife.11491.015Figure 5---figure supplement 1.Transcriptional profiling quality control and additional dTRAF1 validation.Related to [Figure 5](#fig5){ref-type="fig"}. Quality assessment analyses were conducted with post-normalized data. (**A**) Microarrays cluster by condition, indicating that biological effects are driving variability. (**B**) Principle components analysis similarly groups biological replicates. Outliers were not detected in (**A**) or (**B**). (**C**) Density plots of the log~2~ normalized expression in *ptc* domain (*ptc+*) or posterior (*hh+*) samples are very similar in shape and range, further suggesting comparable signal quality between the two arrays. Probe sets with a median log~2~ normalized expression ≥6.5 in *ptc*+ samples, *hh*+ cells, or both, were considered expressed ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}; Materials and methods). This corresponds to 6854 genic probe sets (47.3%). (**D**) Quantile-quantile plot for the differential expression analysis. Based on a criteria of minimum fold change ≥1.5 and false discovery rate (FDR) ≤0.01, 624 of 6,854 genic probe sets (9.1%) are differentially expressed, with 376 (5.5%) upregulated in *ptc+* samples (green) and 248 (3.6%) downregulated in *ptc+* samples (red, [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}; Materials and methods). The dashed line indicates the tuning parameter, *delta*, which is chosen according to the specified FDR (≤0.01). Inhibition of *dTRAF1* expression by a second RNAi line also abolishes pJNK staining (**E**, *ptc\>dTRAF^RNAi\#2^*, and (**F**) leads to a smaller adult wing (red) compared to control (blue). (**G**) Quantification of adult wing size. (**H**) Multiple Ci binding sites (red lines) are identified within the *dTRAF1* gene region (green). Height of red line indicates significance of the binding site. Boxes indicate exons, and arrowed lines indicate introns in the direction of transcription. For box plot, whiskers represent maximum and minimum values. \*\*\*\*=p\<0.0001. Bar: 50 um.**DOI:** [http://dx.doi.org/10.7554/eLife.11491.015](10.7554/eLife.11491.015)10.7554/eLife.11491.016Figure 5---figure supplement 2.Inhibiting *dTRAF1* can modify an activated Ci phenotype.Related to [Figure 5.](#fig5){ref-type="fig"} (**A**) Compared to control wings (blue, *ptc\>*), inhibiting *dTRAF1* while activating Ci still leads to a *dTRAF1* phenotype of a smaller wing (red, *ptc\>Ci^ACT^, dTRAF1^RNAi^*). Compare to [Figure 4E,G](#fig4){ref-type="fig"}. For box plot, whiskers represent maximum and minimum values. \*\*\*=p\<0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.11491.016](10.7554/eLife.11491.016)

*dTRAF1* is expressed along the A/P boundary ([@bib37]) and ectopic expression of *dTRAF1* activates JNK signaling ([@bib9]). Thus, positive regulation of *dTRAF1* expression by Ci could establish a stripe of pJNK that regulates wing size. Indeed, we identified Ci binding motifs in the *dTRAF1* gene ([Figure 5---figure supplement 1H](#fig5s1){ref-type="fig"}), and a previous large-scale ChIP study confirms a Ci binding site within the *dTRAF1* gene (Chr2L: 4367100- 4371393; \[[@bib5]\]). Consistently, a reduction in *Ci* led to a 29% reduction in *dTRAF1* expression in wing discs ([Figure 5J](#fig5){ref-type="fig"}; *ptc-Gal4, UAS-Ci^RNAi^*). Given that the reduction of *dTRAF1* expression in the *ptc* stripe is buffered by Hh-independent *dTRAF1* expression elsewhere in the disc ([@bib37]), this 29% reduction is significant. Furthermore, inhibition of *dTRAF1* by RNAi knockdown abolished pJNK staining ([Figure 5D--E](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1E](#fig5s1){ref-type="fig"}; *ptc-Gal4, UAS-dTRAF1^RNAi\#1or2^*). Finally, these animals have smaller wings without obvious pattern defects ([Figure 5F--I](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1F--G](#fig5s1){ref-type="fig"}). Conversely, overexpression of *dTRAF1* causes embryonic lethality (*ptc-Gal4, UAS-dTRAF1*), making it not possible to attempt to rescue a *dTRAF1* overexpression wing phenotype by knockdown of *bsk*. Nevertheless, it has been shown that dTRAF1 function in the eye is Bsk-dependent ([@bib9]). Finally, inhibition of *dTRAF1* modulates the phenotype of activated Ci signaling (*ptc-Gal4, UAS-dTRAF1^RNAi^, UAS-Ci^ACT^*; [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). Together, these data reveal that the pJNK stripe in the developing wing is established by Hh signaling through Ci-mediated induction of *dTRAF1* expression.

Localized pJNK controls antenna and leg size {#s2-5}
--------------------------------------------

Finally, we detected localized centers of pJNK activity during the development of other imaginal discs including the eye/antenna and leg ([Figures 6A and 6G](#fig6){ref-type="fig"}). Inhibition of localized JNK signaling during development caused a decrease in adult antenna size ([Figures 6B--C and 6F](#fig6){ref-type="fig"}; *dll-Gal4, UAS-bsk^DN^*) and leg size ([Figures 6H--I and 6L](#fig6){ref-type="fig"}; *dll-Gal4, UAS-bsk^DN^*). Conversely, increasing JNK signaling during development resulted in pupal lethality; nevertheless, overall sizes of antenna and leg discs were increased ([Figures 6D--E and 6J--K](#fig6){ref-type="fig"}; *dll-Gal4, UAS-egr*). Together, these data indicate that localized JNK signaling regulates size in other organs in addition to the wing, suggesting a more universal effect of JNK on size control.10.7554/eLife.11491.017Figure 6.Modulation of localized JNK signaling within the developing antenna or leg changes organ size.pJNK (green) staining of wildtype antenna/eye (**A**) and leg (**G**) third instar discs. Inhibition of JNK in the developing antenna (**B-C, F**, *dll\>bsk^DN^*) or leg (**H-I, L**, *dll\>bsk^DN^)* leads to a smaller adult organ. Increased JNK activation within the antenna (**D-E**, *dll\>egr, RFP*, red) or leg disc (**J-K**, *dll\>eg*r*, RFP*, red) causes an increase in disc size. (**M**) Model of how localized JNK signaling regulates wing size during development. Engrailed (En) controls Hh signaling, leading to a stripe of active Ci along the A/P boundary. Ci increases transcription of *dTRAF1*, activating JNK (pJNK, green). JNK acts in a non-canonical, Jun-independent manner to regulate Yki or Yki-dependent signaling. As the human *dTRAF1* homolog, *TRAF4*, and Hippo components are amplified in numerous cancers, these findings provide a new mechanism for how the Hh pathway could contribute to tumorigenesis ([@bib8]; [@bib21]). For box plots, whiskers represent maximum and minimum values (**F, L**). \*\*\*\*=p\<0.0001. Bar: 100 um**DOI:** [http://dx.doi.org/10.7554/eLife.11491.017](10.7554/eLife.11491.017)

Intrinsic mechanisms of organ size control have long been proposed and sought after ([@bib7]; [@bib54]). Our study reveals that in developing *Drosophila* tissues, localized, organ-specific centers of JNK signaling contribute to organ size in an activity level-dependent manner. Such a size control mechanism is qualitatively distinct from developmental morphogen mechanisms, which affect both patterning and growth ([@bib60]). Aptly, this mechanism is still integrated in the overall framework of developmental regulation, as it is established in the wing by the Hh pathway ([Figure 6M](#fig6){ref-type="fig"}). Our data indicate that localized JNK signaling is activated by Ci-mediated induction of *dTRAF1* expression. Furthermore, we discovered that it is not canonical Jun-dependent JNK signaling, but rather non-canonical JNK signaling that regulates size, possibly through Jub-dependent regulation of Yki signaling, as described for regeneration ([@bib48]) ([Figure 6M](#fig6){ref-type="fig"}). As the human *dTRAF1* homolog, *TRAF4*, and Hippo components are amplified in numerous cancers ([@bib8]; [@bib21]), these findings provide a new mechanism for how the Hh pathway could contribute to tumorigenesis. More importantly, these findings offer a new strategy for potential cancer therapies, as reactivating Jun in Hh-driven tumors could lead tumor cells towards an apoptotic fate.

Materials and methods {#s3}
=====================

*Drosophila* stocks and husbandry {#s3-1}
---------------------------------

Fly crosses were maintained at 25°C on standard cornmeal-molasses media unless otherwise indicated (see Experimental Genotypes). When possible, crosses were established so that every experimental animal had an in-vial *Gal4* alone control. For experiments that necessitated precise developmental staging, 2 hr egg lays were conducted on apple juice agar plates with yeast paste. For all other experiments, females were allowed to lay eggs on standard media for 24 hr, after which they were removed and progeny were considered as 12 +/- 12 hr after egg lay. The following stocks were utilized: (1) *Canton-S* (02) *y, hep^r75^, FRT10.1/FM7iGFP* ([@bib18]) (2) *Ubi-GFP, FRT10.1;; hs-FLP, MKRS/TM6B* (3) *UAS-puc* (III) ([@bib30]) (4) *w; ap-GAL4, UAS-src-RFP; Sb/TM6B* (5) *w; ptc-GAL4, UAS-src-RFP; Sb/TM6B* (6) *UAS-bsk^RNAi^*(II and III) VDRC 34138 ([@bib36]) and BDSC 32977 (7) *w, UAS-bsk^DN^ (X)* (8) *w;; UAS-bsk^DN^/TM6B* (9) *w;; rn-GAL4/TM6B* (10) *y, UAS-p35; Adv/CyO; Sb/TM6B* (11) *w; Sp/CyO; UAS-egr/MKRS* (12) *UAS-diap1* (III) BDSC 6657 (13) *UAS-bsk^AY^* (II) BDSC: 6407 (14) *UAS-Ci^RNAi^*(II and III) BDSC 31236 and 31236 (15) *UAS-Ci5m/TK-GFP* ("*UAS-Ci^ACT^*") ([@bib38]) (16) *puc^E69^/TM6B* ("*puc-lacZ*") ([@bib39]) (17) *UAS-dTRAF1^RNAi^*(X and III) VDRC 21213 and 21214 (18) *UAS-jun^RNAi^* (III) BDSC 31595 and VDRC 10835 (19) *UAS-kay^RNAi\#1^* (III) BDSC 33379 and 31322 (20) *UAS-jub^RNAi^*(III and II) BDSC 32923 and 41938 (21) *y,w;; lats^e26-1^/TM6B* (22) *yw; UAS-yki.GFP; Sb/TM6B* BDSC 28815 ([@bib33]) (23) *UAS-yki^RNAi^/TM3* BDSC 31965 (24) *UAS-fj^RNAi^/TM3* BDSC 28009 (25) *UAS-fj.V5* (III) BDSC 44252 (26) *w; dll-Gal4, UAS-src.RFP/CyO* (27) *UAS-dpp^RNAi^*(III) BDSC 25782 (28) *UAS-EGFR^RNAi^*(III) BDSC 25781 (29) *UAS-yki^S111A.S168A.S250A.V5^*(III) BDSC 28817

Imaginal disc staining {#s3-2}
----------------------

Antibody staining was performed according to standard procedures for imaginal discs. The following antibodies were used: rabbit PhosphoDetect^TM^ anti-SAPK/JNK (pThr^183^, pTyr^185^) (1:100, Calbiochem, immunogenic sequence is 100% identical to *D. melanogaster bsk/JNK*), rabbit anti-ACTIVE® JNK (1:100, Promega, immunogenic sequence is 100% identical to *D. melanogaster bsk/JNK*), rabbit anti-cleaved-caspase 3 (1:250, Cell Signaling), mouse anti-betagalactosidase (1:500, Sigma), rabbit anti-pERK (1:75, Cell Signaling), rabbit anti-pSMAD (1:75, Cell Signaling), rabbit anti-phosphorylated histone 3 (1:250, Cell Signaling), goat Alexa-488-conjugated anti-rabbit IgG (1:250, Invitrogen), goat Alexa-488-conjugated anti-mouse IgG (1:250, Invitrogen), goat Alexa-555-conjugated anti-rabbit IgG (1:250, Invitrogen). EdU staining was performed according to established protocol ([@bib19]) using the Click-iT EdU cell proliferation assay kit (Invitrogen), Grace's Media (Invitrogen) and a 10 min EdU incubation.

Imaginal disc imaging {#s3-3}
---------------------

Imaginal discs to be imaged by confocal microscopy were mounted in Vectashield mounting media with DAPI (Vector Labs). Confocal images were taken with a Zeiss LSM510 Meta confocal microscope or a Leica TCS SP8 STEAD 3X confocal microscope with 405nm, 488nm, 561nm, and 633nm lasers. Both microscopes gave similar results. Measurements of disc size were performed from images of at least fifteen discs using NIH Image-J software.

Western blot analysis {#s3-4}
---------------------

Whole *Canton-S* and *hep^r75/Y^* larvae were lysed in standard RIPA buffer with protease and phosphatase inhibitors. Proteins were separated by SDS-PAGE using a 4--15% acrylamide gel (BioRad), transferred for 1 hr at 4°C, and probed with primary antibodies: rabbit anti-pJNK (Calbiochem, 1:1000) and mouse anti-alpha tubulin (Sigma, 1:4000). HRP-conjugated secondary antibodies (anti-rabbit and anti-mouse) were used at 1:5000. ECL (Pierce) was used for detection with film.

Adult organ imaging {#s3-5}
-------------------

Adult wings, legs, or antenna were dissected in 70% ethanol, mounted in Permount mounting media (Fisher Scientific), and imaged with a Leica DFC300FX camera on a Leica MZ FLIII stereomicroscope. Measurements of wing size were performed from images of twenty to sixty female flies using NIH Image-J software. Wing images were false-colored and overlayed to scale using Adobe Photoshop CS3 software. Cell size was measured by dividing the number of hairs (1 hair/cell) by a set area using Adobe Photoshop CS3 software. Mean EdU signal was measured in Adobe Photoshop CS3. Measurements of antenna or leg size were performed from images of at least twenty male flies for each genotype using NIH Image-J software.

Statistical analysis {#s3-6}
--------------------

To determine whether differences in area were statistically significant, two-sided student's t-tests were performed using raw data values, matched for temperature and sex. Box plots were generated where whiskers represent maximum and minimum, a plus sign indicates the mean, a horizontal line within the box indicates the median, and the box represents the 25--75% quartile range. Both parametric and non-parametric analyses were performed, and p-values less than 0.05 were considered significant. Data are presented as relative to the mean of the matched *Gal4*-alone control.

Gene expression profiling {#s3-7}
-------------------------

For each of three biological replicates, 200 pairs of wing imaginal discs were dissected from third instar larvae of the genotypes *hh-Gal4; UAS-mCD8GFP* or *ptc-Gal4; UAS-mCD8GFP*. Discs were stored in Schneider\'s *Drosophila* Media (21720, Invitrogen) plus 10% FBS (10438, Invitrogen) on ice for less than two hours prior to cell dissociation. Discs were washed twice with 1 ml cell dissociation buffer (Sigma, C-1544). Elastase (Sigma, E-0258) was diluted to 0.4 mg/ml in fresh cell dissociation buffer once discs were ready. Discs were incubated for 20 min at room temperature in 0.4 mg/ml elastase with stirring by a magnetic micro stirring bar. Undissociated tissue was spun out, cell viability was measured using the Beckman Vi-CELL Cell Viability Analyzer (\>80%), and cells were immediately isolated using the BD FACSAria II system within the Stanford FACS facility. Dead cells labeled with propidium iodide (P3566, Invitrogen) were excluded during FACS, and purity of sorted cells was greater than 99% by post-sorting FACS analysis. Total RNA was extracted from sorted cells (RNeasy, Qiagen), quality was assessed with the Agilent Bioanalyzer 2100 (RIN \> 7.0), and microarray analysis was performed in the Stanford Protein and Nucleic Acid Facility (Affymetrix *D. mel* GeneChip Genome 2.0 microarrays).

Identification of differentially expressed genes {#s3-8}
------------------------------------------------

All analyses were conducted in R version 3.1.1 (2014-07-10). Expression values were determined using the *affy* package ([@bib17]), available from BioConductor (<http://bioconductor.org>). The automatically downloaded *Drosophila* 2.0 CDF environment was utilized. Probe level data from the *CEL* files were imported using the function *ReadAffy* and converted to expression values using the function *rma* with default settings. This method implements robust multi-array average (RMA) for background correction followed by quantile normalization. PM correction was not performed. Probe level expression values were combined into probe set expression measures using *medianpolish,* the standard summary method employed in RMA ([@bib25]). Expression values are log~2~ transformed.

Post-normalization microarray quality assessment was conducted using the *arrayQualityMetrics* package ([@bib27]), available from BioConductor. Default settings were used, with *ptc* domain (*ptc+*) versus posterior (*hh+*) as the covariate in *intgroup*. Biological replicates cluster together in a dendrogram of inter-array difference, estimated as the mean absolute difference between the data of the arrays ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}), indicating that biological effects are stronger than any batch effects. Similarly, principle components analysis also separates biological replicates into two clusters ([Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}). Outliers were not detected by either of these methods.

Probe sets were mapped to genes using the *drosophila2.db* annotation package (version 3.0.0), available from BioConductor. 14,481 of 18,952 (76.4%) probe sets map to gene isoforms---12,676 (87.5%) of which correspond to unique genes (some genes are mapped by ≥1 probe set). In order to minimize technical artifacts, probe sets mapping to the same gene were not combined.

Based on the distribution observed in the density plot of normalized probe set expression values, probe sets (genes) with median log~2~ expression value ≥6.5 in at least one condition (*ptc+* and/or *hh+*) were considered to be expressed ([Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}). According to these criteria, 7,228 of 18,952 probe sets (38.1%) are expressed. This corresponds to 6,854 of 14,481 gene isoforms (47.3%), which corresponds to 6,397 of 12,676 unique genes (50.4%, [Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}, [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}).

To identify probe sets (genes) differentially expressed between *ptc+* and posterior (*hh+*) samples, we used the *samr* package, an R implementation of significance analysis of microarrays ([@bib51]). This package is available from CRAN (<http://cran.r-project.org/>). Only expressed probe sets mapping to genes (6,854) were considered in this analysis. Differentially expressed probe sets were identified with the function *SAM*, using a two class unpaired response type, the t-statistic as the test statistic, and a false discovery rate (FDR) threshold of 0.01. The maximum number of possible permutations (720) was used. To ensure these results are biologically meaningful, we further trimmed this list to probe sets with a minimum 1.5 fold change between *ptc+* and *hh+* cells. Based on these criteria, 624 of 6,854 probe sets (9.1%) are differentially expressed, with 376 (5.5%) upregulated in *ptc+* samples and 248 (3.6%) downregulated in *ptc+* samples ([Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}, [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}). A gene was considered differentially expressed if any mapped probe set was differentially expressed. Therefore, of the 6,397 unique expressed genes, 604 (9.4%) are differentially expressed, 363 (5.7%) upregulated and 242 (3.8%) downregulated. One gene, *Tie*, was mapped by probe sets both up- and down-regulated. The quantile-quantile plot in [Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"} was prepared using the *samr.plot* function.

Real-time polymerase chain reaction {#s3-9}
-----------------------------------

Total RNA was extracted from third instar wing discs from *ptc-Gal4* or *ptc-Gal4, UAS-Ci^RNAi ^*animals using a standard TriZol extraction. RNA was reverse transcribed using the iScript cDNA Synthesis Kit (Bio-Rad) according to manufacturer's instructions. *dTRAF1* expression was quantified relative to *Rp49 (RpL32*- FlyBase, endogenous control) by real-time PCR performed in triplicate using the SYBR Green fast kit (Applied Biosystems) and an Applied Biosystems machine according to the manufacturer's instructions. The following primers were used: *dTRAF1*, 5'-GCACTCCATCACCTTCACAC-3' and 5'-TAGCTGATCTGGTTCGTTGG-3'; *Rp49*, 5′-GGCCCAAGATCGTGAAGAAG-3′ and 5′-ATTTGTGCGACAGCTTAGCATATC-3′.

Transcription factor binding site analysis {#s3-10}
------------------------------------------

The *Drosophila* Ci positional weight matrix from the BioBase TRANSFAC database was queried against the *Drosophila melanogaster* genome with a p-value \<0.0001 (chosen based on known Ci binding sites within *ptc*) using FIMO (MEME) and aligned back to the UCSC genome browser.

Experimental genotypes {#s3-11}
----------------------

### Crosses were maintained at 25°C unless otherwise indicated {#s3-11-1}

[Figure 1](#fig1){ref-type="fig"}: (B-C) *Canton-S* (D-E) *y, hep*^*r75*^*, FRT10.1 /Y* (F) *y, hep*^*r75*^*, FRT10.1/Ubi-GFP, FRT10.1;; hs-FLP, MKRS/+* (G) *w/+; ptc-GAL4, UAS-src.RFP/+* (H) *w; ptc-GAL4, UAS-src.RFP; UAS-puc* 29°C (I) *w; ptc-GAL4, UAS-src.RFP/UAS-bsk*^*RNAi*^ 29°C

[Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}: (A-C, G-H) *Canton-S*, (D-F) *puc*^*E69*^*/+ *(I) *w; ap-Gal4/+; UAS-puc/+* (J) *w; ptc-Gal4, UAS-src.RFP/+* (K) *w/yv, UAS-bsk*^*RNAi\#1*^*/UAS-src.RFP; rn-Gal4/+* 29°C (L) *w/yv; ptc-Gal4, UAS-src.RFP/+; UAS-bsk*^*RNAi\#2*^*/+*

[Figure 2](#fig2){ref-type="fig"}: (A) *w/+;; rn-Gal4/+* (B) *w/w, UAS-bsk*^*DN*^*;; rn-Gal4/UAS-bsk*^*DN*^ (C) Blue: *w/+;; rn-Gal4/+* Red: *w/w, UAS-bsk*^*DN*^*;; rn-Gal4/UAS-bsk*^*DN*^(D) Blue: *w/+;; rn-Gal4/+* 29°C Red: *w; UAS-bsk*^*RNAi\#1*^*/+; rn-Gal4/+* 29°C (E) Blue: *w/+;; rn-Gal4/+* 29°C Red: *w;; rn-Gal4, UAS-puc/UAS-puc* 29°C (F) Blue: *w/+; ptc-Gal4, UAS-src.RFP/+; Sb/+* Red: *w, UAS-bsk*^*DN*^*/w; ptc-GAL4, UAS-src.RFP/Sp; UAS-bsk*^*DN*^*/Sb* (G) *w, UAS-bsk*^*DN*^*/w, UAS-p35;; rn-GAL4/UAS-bsk*^*DN*^ 29°C (H, P, R) *w/+; ptc-GAL4, UAS-src.RFP/+* (I, Q, S) *w; ptc-GAL4, UAS-src.RFP/+*, *UAS-egr/+* (M) *w/+;; rn-Gal4/+* (N) *w/w, UAS-bsk*^*DN*^*; Sp/+; rn-Gal4/UAS-bsk*^*DN*^

[Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}: (A) Left: *w/+;; rn-Gal4/+* 25°C Right: *w/w, UAS-bsk*^*DN*^*;; rn-Gal4/UAS-bsk*^*DN*^25°C (B) Blue: *w/+; ptc-Gal4, UAS-src.RFP/+; Sb/+* Red: *w/+; ptc-Gal4, UAS-src.RFP/+; Sb/UAS-GFP* (H, J) *w, UAS-bsk*^*DN*^*/w; ap-Gal4, UAS-src.RFP/+; UAS-bsk*^*DN*^*/+* 29°C (L) *w/+;; rn-Gal4/+* 29°C (M) *w/w, UAS-bsk*^*DN*^*;; rn-Gal4/UAS-bsk*^*DN *^29°C (N) *w/+; UAS-bsk*^*AY*^*/+; rn-Gal4/+*

[Figure 2- figure supplement 2](#fig2s2){ref-type="fig"}: (A) *w/+; ptc-Gal4, UAS-src.RFP/+* 6 days AEL (B) *w/+; ptc-Gal4, UAS-src.RFP/+; UAS-egr/Sb* 6 days AEL (D) *w/+; ptc-Gal4, UAS-src.RFP/+* (E) *w/UAS-hid; ptc-Gal4, UAS-src.RFP/+* (G) *w, UAS-bsk*^*DN*^*/w; ptc-Gal4, UAS-src.RFP/+; UAS-egr/UAS-bsk*^*DN*^ (H) *w/+; ptc-Gal4, UAS-src.RFP/UAS-diap1; UAS-egr/Sb* (I) *w/w, UAS-p35; ptc-Gal4, UAS-src.RFP/+; UAS-egr/Sb*

[Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}: (A, D) *w; ap-GAL4/UAS-src.RFP* (B) *w; ap-GAL4/UAS-src.RFP; UAS-EGFR*^*RNAi*^*/+* (C, F) *w/w, UAS-bsk*^*DN*^*; ap-GAL4/UAS-src.RFP; UAS-bsk*^*DN*^*/+* (E) *w; ap-GAL4/UAS-src.RFP; UAS-dpp*^*RNAi*^*/+* (J) *w/+;; rn-Gal4/+* (K) *w;; UAS-dpp*^*RNAi*^*/rn-Gal4* (L) *w/w, UAS-bsk*^*DN*^*;; rn-Gal4/UAS-bsk*^*DN*^

[Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}: (A) *w/yv; ptc-Gal4, UAS-src.RFP/+; UAS-EGFR*^*RNAi*^*/+* (B) *w/yv; ptc-Gal4, UAS-src.RFP/+; UAS-dpp*^*RNAi*^*/+*

[Figure 3](#fig3){ref-type="fig"}: (A) Blue: *w/+; ptc-Gal4, UAS-src.RFP/+* Red: *w/+; ptc-Gal4, UAS-src.RFP/+ UAS-jun*^*RNAi\#1*^*/+* (C) Blue: *w/+; ptc-Gal4, UAS-src.RFP/+* 29°C Red: *w/+; ptc-Gal4, UAS-src.RFP/+; UAS-jub*^*RNAi\#1*^*/+* 29°C (E) Blue: *w/+;; rn-GAL4/+* 29°C Red: *w/w, UAS-bsk*^*DN*^*; UAS-yki.GFP/+; rn-GAL4/UAS-bsk*^*DN *^29°C (G) Blue: *w/+; ptc-Gal4, UAS-src.RFP/+* 29°C Red: *w/w, UAS-bsk*^*DN*^*; ptc-Gal4, UAS-src.RFP/UAS-yki.GFP; UAS-bsk*^*DN*^*/+* 29°C (I) Blue: *w/+; ptc-Gal4, UAS-src.RFP/+* Red: *w/+; ptc-Gal4, UAS-src.RFP/+; UAS-yki*^*RNAi\#1*^*/+* (K) Blue: *w/+; ptc-Gal4, UAS-src.RFP/+* 29°C Red: *w/+; ptc-Gal4, UAS-src.RFP/UAS-yki.GFP* 29°C (M) Blue: *w/+; ptc-Gal4, UAS-src.RFP/+; UAS-yki*^*RNAi\#1*^*/+* Red: *w/ UAS-bsk*^*DN*^*; ptc-Gal4, UAS-src.RFP/+; UAS-yki*^*RNAi\#1*^*/ UAS-bsk*^*DN*^ (O) Blue: *w/+; ptc-Gal4, UAS-src.RFP/UAS-yki.GFP* 29°C Red: *w/+; ptc-Gal4, UAS-src.RFP/UAS-yki.GFP; UAS-fj*^*RNAi*^*/+* 29°C

[Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}: (A) *w/+; ap-Gal4, UAS-src.RFP/+; puc*^*E69*^*/+* (B) *w/+; ap-Gal4, UAS-src.RFP/UAS-jun*^*RNA\#1i*^*; puc*^*E69*^*/+* (C) Blue: *w/+;; rn-Gal4/+* Red: *w/+; UAS-jun*^*RNAi\#1*^*/+; rn-Gal4/+* (E) Blue: *w/+; ptc-Gal4, UAS-src.RFP/+* Red: *w/+; ptc-Gal4, UAS-src.RFP/UAS-jun*^*RNAi\#2 *^(G) Blue: *w/+;; rn-Gal4/+* Red: *w/+;; rn-Gal4/UAS-kay*^*RNAi *^Green: *w/+; UAS-jun*^*RNAi*^*/+; rn-Gal4/UAS-kay*^*RNAi*^

[Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}: (C) Blue: *w/+;; rn-Gal4/+* Red: *w/w, UAS-bsk*^*DN*^*; UAS-bsk*^*DN*^*/+; rn-Gal4/lats*^*e26-1 *^(E) *w; ptc-Gal4, UAS-src.RFP/+; UAS-yki*^*RNAi\#1*^*/UAS-puc* (G) Blue: *w/+; ptc-Gal4, UAS-src.RFP/+* 29°C Red: *w/+; ptc-Gal4, UAS-src.RFP/+; UAS-fj*^*RNAi*^*/+* 29°C (I) Blue: *w/+; ptc-Gal4, UAS-src.RFP/+* Red: *w/+; ptc-Gal4, UAS-src.RFP/UAS-fj; Sb/+*

[Figure 4](#fig4){ref-type="fig"}:(A) *w/+; ptc-Gal4, UAS-src.RFP/+* (B) *w/yv; ptc-Gal4, UAS-src.RFP/+; UAS-Ci*^*RNAi*^*/+* (C) *w/+; ptc-Gal4, UAS-src.RFP/+; UAS-Ci*^*ACT*^*/+* (D) Blue: *w/+; ptc-Gal4, UAS-src.RFP/+* 20°C Red: *w/yv; ptc-Gal4, UAS-src.RFP/+; UAS-Ci*^*RNAi*^*/+* 20°C (E) Blue: *w/+; ptc-Gal4, UAS-src.RFP/+* 20°C Red: *w/+; ptc-Gal4, UAS-src.RFP/+; UAS-Ci*^*ACT*^*/+* 20°C (F) Blue: *w/+; ptc-Gal4, UAS-src.RFP/+; UAS-Ci*^*ACT*^*/+* 20°C Red: *w/UAS-bsk*^*DN*^*; ptc-Gal4, UAS-src.RFP/+; UAS-Ci*^*ACT*^*/UAS-bsk*^*DN*^ 20°C

[Figure 5](#fig5){ref-type="fig"}: (D) *w/+; ptc-Gal4, UAS-src.RFP/+* 29°C (E) *w/+; ptc-Gal4, UAS-src.RFP/+; UAS-dTRAF1*^*RNAi\#1*^*/+* 29°C (F) Blue: *w/+;; rn-Gal4/+* 29°CRed: *w/+;; UAS-dTRAF1*^*RNAi\#1*^*/rn-Gal4* 29°C (G) Blue: *w/+; ptc-Gal4, UAS-src.RFP/+* 29°C Red: *w/+; ptc-Gal4, UAS-src.RFP/+; UAS-dTRAF1*^*RNAi\#1*^*/+* 29°C

[Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}: (E) *UAS-dTRAF1*^*RNAi\#2*^*/Y; ptc-Gal4, UAS-src.RFP/+; Sb/+* 29°C (F) Blue: *w/+; ptc-Gal4, UAS-src.RFP/+* 29°C Red: *w/UAS-dTRAF1*^*RNAi\#2*^*; ptc-Gal4, UAS-src.RFP/+* 29°C

[Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}: (A) Blue: *w/+; ptc-Gal4, UAS-src.RFP/+* 20°C Red: *w/+; ptc-Gal4, UAS-src.RFP/+; UAS-Ci*^*ACT*^*/UAS-dTRAF1*^*RNAi\#1*^ 20°C

[Figure 6](#fig6){ref-type="fig"}: (A, G) *Canton-S* (B, D, H, J) *w; dll-Gal4, UAS-src.RFP/+* (C, I) *UAS-bsk*^*DN*^*/Y; dll-Gal4, UAS-src.RFP/+; UAS-bsk*^*DN*^/+ (E, K) *w; dll-Gal4, UAS-src.RFP/+; UAS-egr/+*
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your work entitled \"Localized JNK Signaling Regulates Organ Size During Development\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors and the evaluation has been overseen by the Reviewing Editor and Fiona Watt as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing editor has drafted this decision to help you prepare a revised submission.

Summary:

In this manuscript, Willsey et al. report a role for localized JNK signaling in regulating *Drosophila* organ size, particularly the developing wing. Mechanistically, Hh signaling from the posterior compartment activates JNK signaling in the A/P boundary by Ci-mediated transcriptional up-regulation of *dTRAF1*. The activated JNK signaling promotes cell proliferation and wing growth through Jun-independent, Jub-dependent Yki activation. While the connection between JNK and Yki has been previously reported, the findings of localized JNK signaling in organ size control and activation of JNK by Hh-Ci pathway are novel and important. However, there are concerns that should be addressed before this manuscript is considered for publication.

Essential revisions:

1\) To verify the specificity of antibody, the authors used *rn-Gal4* and *ptc-Gal4* to knock down *bsk* ([Figure 1I](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1K--L](#fig1s1){ref-type="fig"}). Actually *ap-Gal4* should be used in this situation, as it is expressed only in the dorsal compartment, and the ventral part could serve as an internal control. Similarly, *ap-Gal4* should be used to knock down *hep*, since some p-JNK staining still presents in the *hep* mutant clone ([Figure 1F](#fig1){ref-type="fig"}\').

2\) A control UAS line (e.g. UAS-LacZ or *UAS -GFP*) should be included to exclude the possibility that expression of any protein by *ptc*- or *rn-Gal4* may disturb wing development and affect wing size.

3\) Is there any effect on wing disc size by blocking JNK activity?

4\) Does *ptc*\>*egr*-induced wing disc enlargement depends on Bsk?

5\) Does *ptc*\>*egr* increases the adult wing size?

6\) To show the increased *ptc*\>*egr* wing disc size is not a consequence of apoptosis, authors should block apoptosis by expressing p35.

7\) A positive control should be included to validate CCP3 staining ([Figure 2---figure supplement 1H, I](#fig2s1){ref-type="fig"}).

8\) There is no evidence that the endogenous JNK signaling regulates cell proliferation. The authors should check cell proliferation (Edu staining) in *rn*- or *ptc*\>*bsk^DN^* discs. The non-cell autonomous increase of cell proliferation in *ptc*\>*egr* discs could be triggered by caspase activation, rather than a direct outcome of JNK activation. To discriminate the two possibilities, *diap1* should be added to block caspase activation.

9\) Though Jun is not required by JNK to regulate wing size, what about Fos?

10\) The effect of *UAS-Yki* on *UAS-bsk^DN^* could be additive effect, but not rescue. The authors should check whether *ptc*\> or *rn*\>*bsk^DN^*-induced small wing phenotype could be suppressed in heterozygous *lats* mutants.

11\) *UAS-bsk^DN^* is probably not strong enough to enhance the *ptc*\>*yki^RNAi^*phenotype, what about *UAS-puc*?

12\) Though *fj* appears to be involved in ectopic Yki-triggered wing growth, is it required by endogenous *bsk* and *yki* to regulate wing growth? How do the authors explain this? Is *fj* acting via control of Ft or Ds in this process? To prove this point more clearly, the authors should overexpress *fj* with PtcGal4. Also, does the *fj-lacZ* reporter show a stripe pattern similar to pJNK in the 3rd instar larval wing disc?

13\) Does *dTRAF1^RNAi^* block CiACT-triggered wing growth?

14\) Does expression of *dTRAF1* increase wing size in a Bsk-dependent manner?

15\) Surprisingly, knockdown of Jun did not affect wing size-the authors invoke a non-canonical pathway, but could the knockdown have been incomplete? Also, is there redundancy with Kayak? Similarly, the argument that this signaling is non-canonical is based on the *puc-lacZ* reporter- could this instead be due to delayed reporter activity, or reduced sensitivity?

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Localized JNK Signaling Regulates Organ Size During Development\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Fiona Watt (Senior editor), a Reviewing editor, and two reviewers, one of whom is a member of our Board of Reviewing Editors. The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

The authors have addressed all the concerns well, except two below.

1\) Does expression of *dTRAF1* increase wing size in a Bsk-dependent manner?

The authors responded that ptc\>*dTRAF1* is lethal. What about other *Gal4* drivers, e.g. *rn-Gal4, ap-Gal4*? What Cha et al. showed is that *dTRAF1*-induced cell death depends on JNK. It remains unknown whether *dTRAF1* regulates JNK-dependent cell proliferation and growth. The question is quite crucial for this manuscript.

2\) Redundancy of Kayak. Can the authors provide evidence of the efficacy of their Kayak knockdown. The provided experiment showing that double knockdown of Kayak and Jun has no effect on growth is only worthwhile if the knockdowns are effective.

10.7554/eLife.11491.021

Author response

1\) To verify the specificity of antibody, the authors used rn-Gal4 and ptc-Gal4 to knock down bsk ([Figure 1I](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1K-L](#fig1s1){ref-type="fig"}). Actually ap-Gal4 should be used in this situation, as it is expressed only in the dorsal compartment, and the ventral part could serve as an internal control. Similarly, ap-Gal4 should be used to knock down hep, since some p-JNK staining still presents in the hep mutant clone ([Figure 1F](#fig1){ref-type="fig"}\').

We thank the reviewers for this suggestion. We now use *ap-Gal4* to inhibit JNK signaling in the dorsal compartment and see a specific reduction in pJNK in those cells (*ap*\>*puc*). This data is now included in the text and figures (paragraph one, subheading "JNK is active in the developing Drosophila wing pouch"; [Figure 1---figure supplement 1I](#fig1s1){ref-type="fig"}). *hep^r75^* (used in the clonal analysis) is likely not a null allele since hemizygous mutant embryos complete dorsal closure, which likely explains the minor residual pJNK staining in the mutant clones. Unfortunately none of the available *UAS-hep^RNAi^* lines are strong enough to induce the known *hep* mutant phenotype of a split thorax, nor are they strong enough to abolish pJNK staining (data not shown). So unfortunately we cannot perform this experiment precisely as requested. However, we note that we have done 10 independent experiments to validate the specificity of the antibody and are confident in its fidelity.

2\) A control UAS line (e.g. UAS-LacZ or UAS -GFP) should be included to exclude the possibility that expression of any protein by ptc- or rn-Gal4 may disturb wing development and affect wing size.

We now show that expression of *UAS-GFP* by *ptc-GAL4* does not affect wing size (*ptc*\>*GFP*). We have now included the new data in the text and in the figures (paragraph one, subsection "Localized JNK activity regulates global wing size"; [Figure 2---figure supplement 1B--C](#fig2s1){ref-type="fig"}).

3\) Is there any effect on wing disc size by blocking JNK activity?

We now show that blocking JNK causes a reduction in wing disc size (*ap*\>*bsk^DN^*). We have included the new data in the text and in the figures (paragraph one, aforementioned subsection; [Figure 2---figure supplement 1H--I](#fig2s1){ref-type="fig"}).

4\) Does ptc\>egr-induced wing disc enlargement depends on Bsk?

We now show that *ptc*\>*egr*-induced disc enlargement depends on *bsk (ptc*\>*egr, bsk^DN^*). In fact, these discs are significantly smaller than even control discs (p= 0.0078). We have now included the new data in the text and in the figures (paragraph two, aforementioned subsection; [Figure 2L](#fig2){ref-type="fig"}, disc image in [Figure 2---figure supplement 2G](#fig2s2){ref-type="fig"}).

5\) Does ptc\>egr increases the adult wing size?

We tried to assess whether *ptc*\>*egr* causes an increase in adult wing size, but these animals were larval lethal. The overgrowth of the disc likely precludes proper pupation. We have now added this point to the text (paragraph two, aforementioned subsection).

6\) To show the increased ptc\>egr wing disc size is not a consequence of apoptosis, authors should block apoptosis by expressing p35.

We now show that expression of *UAS-p35* with *UAS-egr* does not abolish the size effect of *UAS-egr (ptc*\>*egr, p35*). We have now included the new data in the text and in the figures (paragraph two, aforementioned subsection; [Figure 2L](#fig2){ref-type="fig"}, disc image in [Figure 2---figure supplement 2I](#fig2s2){ref-type="fig"}).

7\) A positive control should be included to validate CCP3 staining ([Figure 2---figure supplement 1H, I](#fig2s1){ref-type="fig"}).

We now show that expression of *UAS-bsk^AY^*, a constitutively active JNK allele, induces CCP3 staining in the wing. We have now included the new data in the figures ([Figure 2---figure supplement 1N](#fig2s1){ref-type="fig"}).

8\) There is no evidence that the endogenous JNK signaling regulates cell proliferation. The authors should check cell proliferation (Edu staining) in rn- or ptc\>bsk^DN^ discs. The non-cell autonomous increase of cell proliferation in ptc\>egr discs could be triggered by caspase activation, rather than a direct outcome of JNK activation. To discriminate the two possibilities, diap1 should be added to block caspase activation.

We now show that inhibiting JNK signaling causes a reduction in proliferation by phosphorylated histone 3 staining (*ap*\>*bsk^DN^*). We have included this new data in the text and in the figures (paragraph four, aforementioned subsection; [Figure 2---figure supplement 1J-K](#fig2s1){ref-type="fig"}). We now also show that expression of *UAS-diap1* does not block the growth effect of *UAS-egr (ptc*\>*egr, diap1*). We have included this new data in the text and in the figures (paragraph two, same subsection; [Figure 2L](#fig2){ref-type="fig"}, disc image in [Figure 2---figure supplement 2H](#fig2s2){ref-type="fig"}).

9\) Though Jun is not required by JNK to regulate wing size, what about Fos?

We now show that inhibiting Fos does not alter wing size (*rn*\>*kay^RNAi\#1,2^*). We have now included the new data in the text and in the figures (paragraph one, subsection "Non-canonical JNK signaling regulates size"; [Figure 3---figure supplement 1G-H](#fig3s1){ref-type="fig"}).

10\) The effect of UAS-Yki on UAS-bsk^DN^ could be additive effect, but not rescue. The authors should check whether ptc\> or rn\>bsk^DN^-induced small wing phenotype could be suppressed in heterozygous lats mutants.

We now show that the *rn*\>*bsk^DN^* wing phenotype can be partially suppressed in a heterozygous *lats* mutant background (*rn*\>*bsk^DN^; lats^e2b-1/+^*). We have now included the new data in the text and in the figures (paragraph two, same subsection; [Figure 3---figure supplement 2C--D](#fig3s2){ref-type="fig"}).

11\) UAS-bsk^DN^ is probably not strong enough to enhance the ptc\>yki^RNAi^ phenotype, what about UAS-puc?

We now show that *UAS-puc* does not enhance the *ptc*\>*yki^RNAi^*phenotype (*ptc*\>*yki^RNAi^, puc*). We have now included the new data in the text and in the figures (paragraph three, same subsection; [Figure 3---figure supplement 2E--F](#fig3s2){ref-type="fig"}).

12\) Though fj appears to be involved in ectopic Yki-triggered wing growth, is it required by endogenous bsk and yki to regulate wing growth? How do the authors explain this? Is fj acting via control of Ft or Ds in this process? To prove this point more clearly, the authors should overexpress fj with PtcGal4. Also, does the fj-lacZ reporter show a stripe pattern similar to pJNK in the 3rd instar larval wing disc?

We have now overexpressed *fj* and found it also reduces wing size. Therefore, we cannot simply conclude that *fj* is required by endogenous Bsk and/or Yki to regulate growth. We have now made this clear in the text and figures (paragraph four, same subsection; [Figure 3---figure supplement 2I--J](#fig3s2){ref-type="fig"}).

*fj-lacZ* is known to be present in a gradient in the wing disc, highest at the A/P and D/V boundaries, emanating distally (Villano and Katz, 1995). Overall, signaling downstream of Yki is intricate and has not been worked out.

13\) Does dTRAF1^RNAi^ block CiACT-triggered wing growth?

We now show that *UAS-dTRAF^RNAi^* can modulate Ci^ACT^-triggered wing growth (*ptc*\>Ci^ACT^, *dTRAF^RNAi^*), further strengthening our finding. We have now included the new data in the text and in the figures (paragraph three, subsection "Hh sets up pJNK by elevating *dTRAF1* expression"; [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}).

14\) Does expression of dTRAF1 increase wing size in a Bsk-dependent manner?

We tried to determine whether expression of *UAS-dTRAF1* in the *ptc* domain increases wing size in a Bsk-dependent manner, but unfortunately expressing *UAS-dTRAF1* is lethal. Nevertheless, it has been shown that *dTRAF1* function in the eye is Bsk-dependent (Cha et al., 2003). We have now included the new data and discussed this in the text (p. 11-2, para. 2, line 257-259).

15\) Surprisingly, knockdown of Jun did not affect wing size-the authors invoke a non-canonical pathway, but could the knockdown have been incomplete? Also, is there redundancy with Kayak? Similarly, the argument that this signaling is non-canonical is based on the puc-lacZ reporter- could this instead be due to delayed reporter activity, or reduced sensitivity?

Null mutant clones of *jun* do not show a phenotype in the wing (Kockel et al., 1997). Furthermore, *puc-lacZ* is both a sensitive and quick JNK signaling reporter, as indicated by its fast and robust response to JNK activation (McEwen and Peifer, 2005). We note that *UAS-jun^RNAi^* is strong enough to show an effect on *puc-lacZ* expression in the stalk region of the wing ([Figure 3---figure supplement 1A--B](#fig3s1){ref-type="fig"}). We now show that inhibition of *kayak* does not have an effect on wing size (*rn*\>*kay^RNAi^*), and is not redundant with Jun (*rn*\>*jun^RNAi^, kay^RNAi^*). These data are consistent with previous reports that *jun/fos* do not control wing growth (Kockel et al., 1997). We have now included the new data and discussed this in the text (Paragraph one, subsection "Non-canonical JNK signaling regulates size"; [Figure 3---figure supplement 1G--H](#fig3s1){ref-type="fig"}).

*\[Editors\' note: further revisions were requested prior to acceptance, as described below.\] 1) Does expression of dTRAF1 increase wing size in a Bsk-dependent manner?*

*The authors responded that ptc\>dTRAF1 is lethal. What about other Gal4 drivers, e.g. rn-Gal4, ap-Gal4? What Cha et al. showed is that dTRAF1-induced cell death depends on JNK. It remains unknown whether dTRAF1 regulates JNK-dependent cell proliferation and growth. The question is quite crucial for this manuscript.*

The other *Gal4* drivers mentioned (*rn-Gal4* and *ap-Gal4*) express *Gal4* in many more cells than *ptc-Gal4*, so over-expression of *dTRAF1* will certainly be lethal. We show that *dTRAF1* is required for growth and cell proliferation, as inhibition of *dTRAF1* in the wing leads to a small wing phenotype and a loss of pJNK staining ([Figure 5D--I](#fig5){ref-type="fig"}). Indeed, *dTRAF1* null mutants fail to grow during the larval stages and have very small imaginal discs (Cha et al., [Figure 5](#fig5){ref-type="fig"}). This loss of function experiments show that in addition to cell death, *dTRAF1* is involved in regulation of growth.

*2) Redundancy of Kayak. Can the authors provide evidence of the efficacy of their Kayak knockdown. The provided experiment showing that double knockdown of Kayak and Jun has no effect on growth is only worthwhile if the knockdowns are effective.*

These kayak RNAi lines induced the typical JNK-phenotype, thorax closure defect, when driven by *ap-Gal4*, confirming their efficacy. We have added this in the legend of [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}.

[^1]: Department of Anatomy and Regenerative Biology, School of Medicine and Health Sciences, The George Washington University, Washington, United States.

[^2]: School of Life Sciences, Tsinghua University, Beijing, China.
